Temporomandibular joint disorders is a common jaw and face disease caused by various factors common in middle-aged and young people, which are characterized by discomfort, soreness, and TMJ dysfunction, making it difficult to chew, speak, and swallow (
18). According to the current study, 34% of participants had TMD. A few more studies have shown prevalence rates much higher than 25 and 33%, but most earlier investigations estimated the prevalence of TMD to be between 5 and 12% in the general population (
6).
This study aimed to translate and check the validity and reliability of the Persian translation of the standard DC/TMD questionnaire as a practical and valuable global tool in temporomandibular disorders.
The results of this study can help Persian language researchers of the temporomandibular area in extensive research and screening of large communities to investigate temporomandibular disorders so that these researchers can use this questionnaire as a practical tool for quick and effective screening of patients in large communities.
The DC/TMD is a comprehensive diagnostic tool, including Axis I and II components. DC/TMD Axis I is used to diagnose TMD based on clinical and imaging examinations. Axis I includes a standardized clinical examination protocol and a set of diagnostic criteria based on physical signs and symptoms. The clinical examination protocol includes the assessment of joint sounds, range of motion, and palpation of the masticatory muscles and TMJ. The diagnostic criteria include both specific and non-specific TMD diagnoses, such as disc displacement, osteoarthritis, myofascial pain, and headache attributed to TMD (
20).
Temporomandibular joint disorders's psychological and behavioral aspects are evaluated using the DC/TMD Axis II. Axis II consists of several validated questionnaires that measure psychological distress, behavioral variables, and pain-related impairments probably associated with TMD symptoms. The Patient Health Questionnaire (PHQ), the Graded Chronic Pain Scale (GCPS), and the Oral Behaviors Checklist (OBC) are the questionnaires utilized in Axis II. The psychological and behavioral aspects that may influence TMD symptoms can be evaluated using the DC/TMD Axis II questionnaires. Anxiety, sadness, stress, and dental habits like grinding or clenching teeth can be contributing causes. The validated questionnaires used in Axis II provide valuable information that can aid in developing effective treatment strategies (
20). Additionally, all Axis II instruments have been separated into separate documents, and demographic questions are placed in a separate document. This modular organization enhances flexibility in adapting the DC/TMD protocol to specific settings. For instance, one setting may use only the Axis II screening instruments, while another may utilize the complete Axis II instruments. Similarly, one setting might gather demographic information through an existing mandatory clinic registration form, while another may require a separate form for research purposes (
20,
22).
The DC/TMD Symptom Questionnaire is part of Axis I of the DC/TMD to diagnose TMD based on clinical and imaging examinations. The DC/TMD Symptom Questionnaire is a tool developed to assess the presence and severity of TMD symptoms. The questionnaire consists of 12 items that assess the frequency and severity of pain, restricted jaw movement, and other TMD-related symptoms (
20). According to the developer of the DC/TMD, the Patient History Questionnaire (PHQ) of the RDC/TMD has undergone a complete revision for the DC/TMD, resulting in its renaming as the Symptom Questionnaire (SQ) to differentiate it from the pre-existing PHQ-9 and PHQ-15 developed independently of the DC/TMD. There are several notable differences between the RDC/TMD PHQ and the DC/TMD SQ. Firstly, the DC/TMD SQ primarily focuses on Axis I diagnostic requirements (excluding the pain chronicity question). The TMD pain screener was initially designed as a stand-alone screening instrument suitable for various settings. The DC/TMD SQ now includes most of the TMD pain screener's scope, but there is a difference in the pain-related filter item between the two instruments. The TMD pain screener focuses on pain in the jaw or temple area to maximize specificity about other conditions that can cause TMD-like pain. In contrast, the DC/TMD SQ aims to be more inclusive and asks about pain in the jaw, temple, ear, or front of the ear, with confirmation through clinical examination. The potential impact of this difference in wording on the outcomes is yet to be determined empirically or logically. The DC/TMD SQ alone will suffice as the pain history collection instrument in many settings, rendering the TMD pain screener unnecessary. However, there may be settings where only the TMD pain screener is required. Translating both instruments is essential to provide a complete set of language instruments for all users in a particular language setting (
20,
22).
The validity and reliability of the DC/TMD Symptom Questionnaire's Persian translation were evaluated in the current study using a dentistry sample. The Persian translation exhibited outstanding reliability (ICC coefficient of 0.98) and strong internal consistency (Cronbach's alpha value of 0.90 or higher). The content validity index (CVI) was 0.95, indicating satisfactory content validity.
The ability to translate the DC/TMD Symptom Questionnaire into different languages is important because it allows for standardized assessment of TMD symptoms across diverse populations and languages. This facilitates cross-cultural research and improves diagnostic accuracy, which can lead to better patient outcomes and quality of life. Furthermore, the availability of valid and reliable translated versions of the questionnaire allows for comparing TMD prevalence and severity across different and large populations, which can develop effective TMD treatment strategies.
5.1. Strengths and Limitations
As validated in the present study, the Persian translation of the DC/TMD Symptom Questionnaire is a valuable tool for assessing TMD symptoms in the Persian-speaking population. This questionnaire has been translated into Farsi for the first time, and researchers can utilize it as a screening tool in their studies. Additionally, clinicians can use it to assess patients' progress during treatment. It is crucial to remember that the DC/TMD SQ's validity and reliability should be evaluated among multiple groups and a broader population, and the questionnaire alone is insufficient for diagnosing TMD. A thorough clinical examination and diagnostic imaging are also necessary to ensure accurate diagnosis and treatment planning.
5.2. Conclusions
The Kaiser-Meyer-Olkin (KMO) index was 0.62 for the entire questionnaire, indicating that the questions were acceptable. The KMO index is a number between 0 and 1 calculated for each question and the questionnaire. A value above 0.5 is acceptable for individual questions, and a value above 0.6 is acceptable for the entire questionnaire. Therefore, the questionnaire questions were acceptable and significant at a desirable level.
Additionally, Bartlett's test was significant (P = 0.0001), indicating the presence of a relationship between the questions in the questionnaire. Therefore, the data has a 95% chance of being effective, and the questionnaire has acceptable validity (
Table 1).
In addition, the Persian translation exhibited outstanding reliability (ICC coefficient of 0.98) and strong internal consistency (Cronbach's alpha value of 0.90 or higher). The content validity index (CVI) of 0.95 indicates satisfactory content validity.
Based on the results, the DC/TMD Symptom Questionnaire is a validated tool that can aid in assessing TMD symptoms. The availability of translated versions of the questionnaire allows for the standardized evaluation of TMD symptoms across different populations and languages, facilitating cross-cultural research and improving diagnostic accuracy. The Persian version of the questionnaire can be used in clinical settings for TMD diagnosis and evaluation in Persian-speaking populations. The study has important implications for clinical practice. Conducting further studies to assess the reliability and validity of the DC/TMD Symptom Questionnaire in different populations and larger groups would be beneficial.